TY - JOUR A1 - Bhuckory, S. A1 - Wegner, Karl David A1 - Qiu, X. A1 - Wu, Y.T. A1 - Jennings, T. L. A1 - Incamps, A. A1 - Hildebrandt, N. T1 - Triplexed CEA-NSE-PSA Immunoassay Using Time-Gated Terbium-to-Quantum Dot FRET N2 - Time-gated Förster resonance energy transfer (TG-FRET) between Tb complexes and luminescent semiconductor quantum dots (QDs) provides highly advantageous photophysical properties for multiplexed biosensing. Multiplexed Tb-to-QD FRET immunoassays possess a large potential for in vitro diagnostics, but their performance is often insufficient for their application under clinical conditions. Here, we developed a homogeneous TG-FRET immunoassay for the quantification of carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), and prostatespecific antigen (PSA) from a single serum sample by multiplexed Tb-to-QD FRET. Tb–IgG antibody donor conjugates were combined with compact QD-F(ab’)2 antibody acceptor conjugates with three different QDs emitting at 605, 650, and 705 nm. Upon antibody–antigen–antibody Sandwich complex formation, the QD acceptors were sensitized via FRET from Tb, and the FRET ratios of QD and Tb TG luminescence intensities increased specifically with increasing antigen concentrations. Although limits of detection (LoDs: 3.6 ng/mL CEA, 3.5 ng/mL NSE, and 0.3 ng/mL PSA) for the triplexed assay were slightly higher compared to the single-antigen assays, they were still in a clinically relevant concentration range and could be quantified in 50 μL serum samples on a B·R·A·H·M·S KRYPTOR Compact PLUS clinical immunoassay plate reader. The simultaneous quantification of CEA, NSE, and PSA at different concentrations from the same serum sample demonstrated actual multiplexing Tb-to-QD FRET immunoassays and the potential of this technology for translation into clinical diagnostics. KW - Lanthanides KW - Nanoparticles KW - Biosensing KW - Multiplexing KW - FRET KW - Fluorescence KW - PSA KW - NSE KW - CEA PY - 2020 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-512290 DO - https://doi.org/10.3390/molecules25163679 VL - 25 IS - 16 SP - 3679 PB - MDPI AN - OPUS4-51229 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Kang, Y. A1 - Nack, L. M. A1 - Liu, Y. A1 - Qi, B. A1 - Huang, Y. A1 - Liu, Z. A1 - Chakraborty, I. A1 - Schulz, F. A1 - Ahmed, A. A. A. A1 - Poveda, M. C. A1 - Hafizi, F. A1 - Roy, S. A1 - Mutas, M. A1 - Holzapfel, M. A1 - Sanchez-Cano, C. A1 - Wegner, Karl David A1 - Feliu, N. A1 - Parak, W. J. T1 - Quantitative considerations about the size dependence of cellular entry and excretion of colloidal nanoparticles for different cell types N2 - Most studies about the interaction of nanoparticles (NPs) with cells have focused on how the physicochemical properties of NPs will influence their uptake by cells. However, much less is known about their potential excretion from cells. However, to control and manipulate the number of NPs in a cell, both cellular uptake and excretion must be studied quantitatively. Monitoring the intracellular and extracellular amount of NPs over time (after residual noninternalized NPs have been removed) enables one to disentangle the influences of cell proliferation and exocytosis, the major pathways for the reduction of NPs per cell. Proliferation depends on the type of cells, while exocytosis depends in addition on properties of the NPs, such as their size. Examples are given herein on the role of these two different processes for different cells and NPs. KW - Cell proliferation KW - Exocytosis KW - Gold nanoparticles KW - Quantum dots KW - Fluorescence KW - Uptake studies PY - 2022 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-543476 DO - https://doi.org/10.1007/s40828-021-00159-6 SN - 2199-3793 VL - 8 IS - 1 SP - 1 EP - 8 PB - Springer CY - Berlin AN - OPUS4-54347 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Kang, Y. A1 - Nack, L. A1 - Liu, Y. A1 - Qi, B. A1 - Huang, Y. A1 - Liu, Z. A1 - Chakraborty, I. A1 - Schulz, F. A1 - Ahmed, A. A. A1 - Poveda, M. C. A1 - Hafizi, F. A1 - Roy, S. A1 - Mutas, M. A1 - Holzapfel, M. A1 - Sanchez-Cano, C. A1 - Wegner, Karl David A1 - Feliu, N. A1 - Parak, W. J. T1 - Correction to: Quantitative considerations about the size dependency for cellular entry and excretion of colloidal nanoparticles for different cell types N2 - We regret to inform that the labels "NPs which remain in endosomes/lysosomes" and "exocytosed NPs" had been erroneously swapped in the sketch on the right side in Figure 2. The corrected Fig. 2 is displayed below. WJP apologizes for this error. PY - 2022 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-554519 DO - https://doi.org/10.1007/s40828-022-00168-z VL - 8 IS - 17 SP - 1 EP - 2 PB - Springer CY - Berlin AN - OPUS4-55451 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Godard, A. A1 - Kalot, G. A1 - Privat, M. A1 - Bendellaa, M. A1 - Busser, B. A1 - Wegner, Karl David A1 - Denat, F. A1 - Le Guevel, X. A1 - Coll, J.-L. A1 - Paul, C. A1 - Bodio, E. A1 - Goze, C. A1 - Sancey, L. T1 - NIR-II Aza-BODIPY Dyes Bioconjugated to Monoclonal Antibody Trastuzumab for Selective Imaging of HER2-Positive Ovarian Cancer N2 - Using fluorescence-guided surgery (FGS) to cytoreductive surgery helps achieving complete resection of microscopic ovarian tumors. The use of visible and NIR-I fluorophores has led to beneficial results in clinical trials; however, involving NIR-II dyes seems to outperform those benefits due to the deeper tissue imaging and higher signal/noise ratio attained within the NIR-II optical window. In this context, we developed NIR-II emitting dyes targeting human epidermal growth factor receptor 2 (HER2)-positive ovarian tumors by coupling water-soluble NIR-II aza-BODIPY dyes to the FDA-approved anti-HER2 antibody, namely, trastuzumab. These bioconjugated NIR-II-emitting dyes displayed a prolonged stability in serum and a maintained affinity toward HER2 in vitro. We obtained selective targeting of HER2 positive tumors (SKOV-3) in vivo, with a favorable tumor accumulation. We demonstrated the fluorescence properties and the specific HER2 binding of the bioconjugated dyes in vivo and thus their potential for NIR-II FGS in the cancer setting. KW - NIR-II KW - Fluorescent dye KW - In vivo imaging KW - Ovarian cancer KW - Antibody conjuagtes KW - Bioimaging PY - 2023 DO - https://doi.org/10.1021/acs.jmedchem.3c00100 SN - 0022-2623 VL - 66 IS - 7 SP - 5185 EP - 5195 PB - ACS Publications AN - OPUS4-57293 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Chazeau, E. A1 - Fabre, C. A1 - Privat, M. A1 - Godard, A. A1 - Racoeur, C. A1 - Bodio, E. A1 - Busser, B. A1 - Wegner, Karl David A1 - Sancey, L. A1 - Paul, C. A1 - Goze, C. T1 - Comparison of the In Vitro and In Vivo Behavior of a Series of NIR-II-Emitting Aza-BODIPYs Containing Different Water-Solubilizing Groups and Their Trastuzumab Antibody Conjugates N2 - The development of new fluorescent organic probes effective in the NIR-II region is currently a fast-growing field and represents a challenge in the domain of medical imaging. In this study, we have designed and synthesized an innovative series of aza-boron dipyrromethenes emitting in the NIR-II region. We have investigated the effect of different water-solubilizing groups not only on the photophysical properties of the compounds but also on their in vitro and in vivo performance after bioconjugation to the antibody trastuzumab. Remarkably, we discovered that the most lipophilic compound unexpectedly displayed the most favorable in vivo properties after bioconjugation. This underlines the profound influence that the fluorophore functionalization approach can have on the efficiency of the resulting imaging agent. KW - NIR-II KW - In vivo imaging KW - Fluorescence KW - Spectroscopy KW - Antibody conjugates PY - 2024 DO - https://doi.org/10.1021/acs.jmedchem.3c02139 SN - 1520-4804 VL - 67 IS - 5 SP - 3679 EP - 3691 PB - ACS Publications CY - Washington, DC AN - OPUS4-59607 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Wegner, Karl David A1 - Hildebrandt, N. T1 - Near infrared quantum dots for biosensing and bioimaging N2 - Quantum dots (QDs) possess unique optoelectronic properties, which make them very attractive to be used as optical probes in biosensing and bioimaging applications. The strong absorbance and light scattering of biological compounds like tissue and blood in the visible range pose a problem. However, if optical probes emitting in the near-infrared (NIR) range are used, scattering, absorption, and autofluorescence of biological components are strongly reduced. This allows for an increased light penetration depth and higher spatial and temporal resolution for the investigation of biological processes. The synthesis and application of NIR emitting QDs is a fast-growing research field and the benefits of using QDs were demonstrated for a variety of applications, such as photoelectrochemical biosensor, in vivo vascular imaging, and fluorescence-guided surgery. This article reviews the state-of-the-art developments in the preparation of NIR/IR QDs and highlights the latest research about their utilization in biosensing and bioimaging applications. KW - Quantum dots KW - Near-infrared KW - Biosensing KW - Bioimaging KW - NIR-II / SWIR KW - Advanced nanomaterials PY - 2024 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-609708 SN - 0165-9936 DO - https://doi.org/10.1016/j.trac.2024.117922 VL - 180 SP - 1 EP - 19 PB - Elsevier B.V. AN - OPUS4-60970 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Jin, Z. A1 - Geißler, Daniel A1 - Qiu, X. A1 - Wegner, Karl David A1 - Hildebrandt, N. T1 - A rapid, amplification-free, and sensitive diagnostic assay for single-step multiplexed fluorescence detection of microRNA N2 - The importance of microRNA (miRNA) dysregulation for the development and progression of diseases and the discovery of stable miRNAs in peripheral blood have made these short-sequence nucleic acids next-generation biomarkers. Here we present a fully homogeneous multiplexed miRNA FRET assay that combines careful biophotonic design with various RNA hybridization and ligation steps. The single-step, single-temperature, and amplification-free assay provides a unique combination of performance parameters compared to state-of-the-art miRNA detection technologies. Precise multiplexed quantification of miRNA-20a, -20b, and -21 at concentrations between 0.05 and 0.5 nm in a single 150 mL sample and detection limits between 0.2 and 0.9 nm in 7.5 mL serum samples demonstrate the feasibility of both highthroughput and point-of-care clinical diagnostics. KW - Clinical diagnostics KW - FRET KW - MicroRNA KW - Multiplexing KW - Time-gated fluorescence detection PY - 2015 DO - https://doi.org/10.1002/anie.201504887 SN - 1433-7851 SN - 1521-3773 VL - 54 IS - 34 SP - 10024 EP - 10029 PB - Wiley-VCH CY - Weinheim AN - OPUS4-44837 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Santos, C.I.L. A1 - Machado, W.S. A1 - Wegner, Karl David A1 - Gontijo, L.A.P. A1 - Bettini, J. A1 - Schiavon, M.A. A1 - Reiss, P. A1 - Aldakov, D. T1 - Hydrothermal Synthesis of Aqueous-Soluble Copper Indium Sulfide Nanocrystals and Their Use in Quantum Dot Sensitized Solar Cells N2 - facile hydrothermal method to synthesize water-soluble copper indium sulfide (CIS) nanocrystals (NCs) at 150 degrees C is presented. The obtained samples exhibited three distinct photoluminescence peaks in the red, green and blue spectral regions, corresponding to three size fractions, which could be separated by means of size-selective precipitation. While the red and green emitting fractions consist of 4.5 and 2.5 nm CIS NCs, the blue fraction was identified as in situ formed carbon nanodots showing excitation wavelength dependent emission. When used as light absorbers in quantum dot sensitized solar cells, the individual green and red fractions yielded power conversion efficiencies of 2.9% and 2.6%, respectively. With the unfractionated samples, the efficiency values approaching 5% were obtained. This improvement was mainly due to a significantly enhanced photocurrent arising from complementary panchromatic absorption. KW - Aqueous quantum dot KW - Solar cells KW - CUINS2 nanocrystals KW - Colloidal semiconductor nanocrystals PY - 2020 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-517983 DO - https://doi.org/10.3390/nano10071252 VL - 10 IS - 7 SP - 1252 PB - MDPI AN - OPUS4-51798 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Geißler, Daniel A1 - Linden, S. A1 - Liermann, K. A1 - Wegner, Karl David A1 - Charbonnière, L.J. A1 - Hildebrandt, N. T1 - Lanthanides and quantum dots as Förster resonance energy transfer agents for diagnostics and cellular imaging N2 - Luminescent lanthanide labels (LLLs) and semiconductor quantum dots (QDs) are two very special classes of (at least partially) inorganic fluorophores, which provide unique properties for Förster resonance energy transfer (FRET). FRET is an energy-transfer process between an excited donor fluorophore and a ground-state acceptor fluorophore in close proximity (approximately 1–20 nm), and therefore it is extremely well suited for biosensing applications in optical spectroscopy and microscopy. Within this cogent review, we will outline the main photophysical advantages of LLLs and QDs and their special properties for FRET. We will then focus on some recent applications from the FRET biosensing literature using LLLs as donors and QDs as donors and acceptors in combination with several other fluorophores. Recent examples of combining LLLs and QDs for spectral and temporal multiplexing from single-step to multistep FRET demonstrate the versatile and powerful biosensing capabilities of this unique FRET pair. As this review is published in the Forum on Imaging and Sensing, we will also present some new results of our groups concerning LLL-based time-gated cellular imaging with optically trifunctional antibodies and LLL-to-QD FRET-based homogeneous sandwich immunoassays for the detection of carcinoembryonic antigen. PY - 2014 DO - https://doi.org/10.1021/ic4017883 SN - 0020-1669 SN - 1520-510X VL - 53 IS - 4 SP - 1824 EP - 1838 PB - American Chemical Society CY - Washington, DC AN - OPUS4-31182 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Chazeau, E. A1 - Pipier, A. A1 - Wegner, Karl David A1 - Ghiringhelli, F. A1 - Sancey, L. A1 - Paul, C. A1 - Goze, C. T1 - NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate N2 - Real-time imaging of antibody-drug conjugates (ADCs) offers valuable insights for assessing tumor targeting specificity, monitoring therapeutic efficacy, and detecting off-target accumulation that may cause adverse effects. To enable precise tracking, we developed a versatile fluorescent platform based on an NIR-II emitting aza-BODIPY dye, which can be site-specifically grafted onto an IgG1 antibody to generate well-defined fluorescent ADCs. As a proof of concept, we synthesized an HER2-targeting trastuzumab immunoconjugate bearing a NIR-II aza-BODIPY fluorophore. The cytotoxic monomethyl auristatin E (MMAE) payload was introduced in the final step, resulting in a trackable and homogeneous ADC suitable for both in vitro and in vivo investigations. The resulting Trastu-azaNIRII-MMAE selectively accumulated in HER2-positive subcutaneous tumors, significantly reducing the tumor growth. Using NIR-II optical imaging, a single injection of the NIR-II-ADC allowed for the detection of the conjugate over a period of more than one month, highlighting its potential for long-term tracking and therapeutic applications. KW - NIR-II KW - Fluorescence KW - Quality assurance KW - Antibody drug conjugate KW - In vivo imaging PY - 2025 DO - https://doi.org/10.1021/acs.jmedchem.4c02777 VL - 68 IS - 7 SP - 7232 EP - 7242 PB - ACS Publications AN - OPUS4-63025 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Wang, P. A1 - Morales-Marquez, R. A1 - Cervas, G. A1 - Hernandez Medel, A. A1 - Ogayar, M. P. A1 - Jimenez de Aberasturi, D. A1 - de Isidro-Gomez, A. I. A1 - Torres-Padro, A. A1 - Palomares, F. J. A1 - Garcia-Orrit, S. A1 - Sousa, C. T. A1 - Espinosa, A. A1 - Telle, H. H. A1 - Ortgies, D. H. A1 - Vega-Mayoral, V. A1 - Cabanillas-Gonzalez, J. A1 - Rodriguez, E. M. A1 - Resch-Genger, Ute A1 - Wegner, Karl David A1 - Juarez, B. H. T1 - The role of temperature in the photoluminescence quantum yield (PLQY) of Ag2S-based nanocrystals N2 - Highly emissive Ag2S nanocrystals (NCs) passivated with a gradated shell incorporating Se and Zn were synthesized in air, and the temperature dependence of their photoluminescence quantum yield (PLQY) was quantified in both organic and aqueous media at B1200 nm. The relevance of this parameter, measured at physiological temperatures, is highlighted for applications that rely on the near infrared (NIR) photoluminescence of NCs, such as deep NIR imaging or luminescence nanothermometry. Hyperspectral NIR imaging shows that Ag2S-based NCs with a PLQY in organic media of about 10% are inefficient for imaging at 40 8C through 20 mm thick tissue with low laser irradiation power densities. In contrast, water-transferred Ag2S-based NCs with an initial PLQY of 2% in water exhibit improved robustness against temperature changes, enabling improved imaging performance. KW - Quantum dots KW - Ag2S KW - Fluorescence KW - Nanomaterial design KW - Advanced nanomaterials KW - Shortwave infrared (SWIR) KW - Temperature sensing PY - 2024 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-613877 DO - https://doi.org/10.1039/D4MH01016G SP - 1 EP - 11 PB - Royal Society of Chemistry (RSC) AN - OPUS4-61387 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -